Your browser doesn't support javascript.
loading
[Efficacy of different regimens and prognostic factors in patients with first relapsed multiple myeloma treated after front-line bortezomib, cyclophosphamide, and dexamethasone].
Chen, M; Fan, Q; Li, H; Ma, Y P; Qin, X Q; Suo, X H; Yang, C; Zhu, T N; Duan, M H; Han, B; Wang, S J; Zhou, D B; Zhuang, J L.
Afiliação
  • Chen M; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Fan Q; Department of Hematology, Beijing Shunyi Hospital, Beijing 101399, China.
  • Li H; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Ma YP; Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Qin XQ; Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan 030001, China.
  • Suo XH; Department of Hematology, Handan Central Hospital, Handan 057150, China.
  • Yang C; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Zhu TN; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Duan MH; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Han B; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Wang SJ; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Zhou DB; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
  • Zhuang JL; Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
Zhonghua Nei Ke Za Zhi ; 62(12): 1436-1443, 2023 Dec 01.
Article em Zh | MEDLINE | ID: mdl-38044070
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Nei Ke Za Zhi Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China